Vita Life Sciences Ltd
ASX:VLS
Gross Margin
Vita Life Sciences Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| AU |
|
Vita Life Sciences Ltd
ASX:VLS
|
134.6m AUD |
59%
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
734.9B USD |
82%
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
56%
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
366.6B USD |
68%
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK |
84%
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
208.1B CHF |
74%
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
188.4B CHF |
76%
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
158.5B GBP |
82%
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
199B USD |
78%
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
68%
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
137.5B USD |
75%
|
Vita Life Sciences Ltd
Glance View
Vita Life Sciences Ltd. engages in the formulation, packaging, sale and distribution of vitamins and supplements. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-08-23. The firm is involved in the formulating, packaging, sales and distributing vitamins and supplements. The Company’s core business is the development and distribution of over the counter (OTC) medicines, as well as complementary and alternative medicines, dietary supplements and health foods under various brand names throughout Australia, Malaysia, Singapore, Thailand, Vietnam, China and Indonesia. The company offers products under the brands, such as Herbs of Gold, VitaHealth, VitaScience and VitaLife. The firm operates in Australia, Singapore, Malaysia and others. The firm subsidiaries include Tetley Research Pty Limited, Tetley Treadmills Pty Limited, Tetley Manufacturing Pty Limited, Vimed Bio Sciences Pty Limited, Allrad No 19 Pty Limited, Lovin Pharma International Limited, Herbs of Gold Pty Limited, VitaHealth Laboratories Australia Pty Limited and Vita Institute of Health Pty Ltd.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Vita Life Sciences Ltd's most recent financial statements, the company has Gross Margin of 59.4%.
You don't have any saved screeners yet